These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 209772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T.
    Cancer; 1984 Feb 01; 53(3):430-40. PubMed ID: 6318948
    [Abstract] [Full Text] [Related]

  • 5. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P.
    Acta Otorrinolaringol Esp; 1992 Feb 01; 43(1):31-6. PubMed ID: 1316136
    [Abstract] [Full Text] [Related]

  • 6. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC, Chen JY, Glaser R, Henle W.
    Proc Natl Acad Sci U S A; 1980 Oct 01; 77(10):6162-5. PubMed ID: 6255477
    [Abstract] [Full Text] [Related]

  • 7. Anti-EBV serologic tests for nasopharyngeal carcinoma.
    Neel HB, Pearson GR, Weiland LH, Taylor WF, Goepfert HH, Pilch BZ, Lanier AP, Huang AT, Hyams VJ, Levine PH, Henle G, Henle W.
    Laryngoscope; 1980 Dec 01; 90(12):1981-90. PubMed ID: 6256597
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck.
    Ringborg U, Henle W, Henle G, Ingimarsson S, Klein G, Silfversward C, Strander H.
    Cancer; 1983 Oct 01; 52(7):1237-43. PubMed ID: 6309355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte response.
    Sundar SK, Ablashi DV, Kamaraju LS, Levine PH, Faggioni A, Armstrong GR, Pearson GR, Krueger GR, Hewetson JF, Bertram G, Sesterhenn K, Menezes J.
    Int J Cancer; 1982 Apr 15; 29(4):407-12. PubMed ID: 6282765
    [Abstract] [Full Text] [Related]

  • 12. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC.
    Bull Cancer Radiother; 1996 Apr 15; 83(1):3-7. PubMed ID: 8679277
    [Abstract] [Full Text] [Related]

  • 13. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
    Hewetson JF, Levine PH, Neubauer RH, Rabin H.
    Int J Cancer; 1982 Nov 15; 30(5):581-5. PubMed ID: 6295966
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
    Neel HB, Pearson GR, Taylor WF.
    Ann Otol Rhinol Laryngol; 1984 Nov 15; 93(5 Pt 1):477-82. PubMed ID: 6093669
    [Abstract] [Full Text] [Related]

  • 15. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
    Gurtsevich VE, Ruíz García R, Cuevas J, Le Riverand Morales E, Ascue M.
    Vopr Virusol; 1979 Nov 15; (4):392-9. PubMed ID: 225887
    [Abstract] [Full Text] [Related]

  • 16. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX, Zeng Y, Wolf H.
    Int J Cancer; 1986 May 15; 37(5):689-91. PubMed ID: 3009331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specific Epstein-Barr virus serological response in patients with nasopharyngeal carcinoma detected by immunoblotting.
    Cevenini R, Donati M, Moroni A, Caliceti U, Rinaldi-Ceroni A, La Placa M.
    Eur J Epidemiol; 1988 Sep 15; 4(3):301-5. PubMed ID: 2846341
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.